Nonthavej Hospital PCL (BKK:NTV)
Thailand · Delayed Price · Currency is THB 18.50
-0.10 (-0.54%)
Jun 12, 2026, 3:45 PM ICT
Nonthavej Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,325 | 2,372 | 2,484 | 2,472 | 2,255 | 1,786 |
Other Revenue | 15.11 | 13.7 | 15.57 | 13.19 | 14.83 | 16.13 |
| 2,341 | 2,386 | 2,500 | 2,485 | 2,270 | 1,802 | |
Revenue Growth (YoY) | -5.51% | -4.56% | 0.61% | 9.45% | 25.98% | -4.76% |
Cost of Revenue | 1,731 | 1,735 | 1,744 | 1,707 | 1,599 | 1,345 |
Gross Profit | 609.89 | 651.06 | 755.76 | 777.82 | 671.24 | 457.29 |
Selling, General & Admin | 328.28 | 329.43 | 328.42 | 311.51 | 290.96 | 262.07 |
Operating Expenses | 325.58 | 327.5 | 325.21 | 306.18 | 300.65 | 266.56 |
Operating Income | 284.31 | 323.56 | 430.55 | 471.64 | 370.59 | 190.73 |
Interest & Investment Income | 19.87 | 21.72 | 19.02 | 11.69 | 4.54 | 3.56 |
EBT Excluding Unusual Items | 304.17 | 345.29 | 449.57 | 483.33 | 375.13 | 194.3 |
Gain (Loss) on Sale of Investments | 0.21 | -0.03 | -0.17 | -0.08 | -0.19 | 0.19 |
Pretax Income | 304.38 | 345.25 | 449.4 | 483.25 | 374.94 | 194.49 |
Income Tax Expense | 60.06 | 68.5 | 88.66 | 95.5 | 74.37 | 35.12 |
Net Income | 244.32 | 276.76 | 360.74 | 387.75 | 300.56 | 159.37 |
Net Income to Common | 244.32 | 276.76 | 360.74 | 387.75 | 300.56 | 159.37 |
Net Income Growth | -30.23% | -23.28% | -6.96% | 29.01% | 88.59% | -30.95% |
Shares Outstanding (Basic) | 160 | 160 | 160 | 160 | 160 | 160 |
Shares Outstanding (Diluted) | 160 | 160 | 160 | 160 | 160 | 160 |
EPS (Basic) | 1.53 | 1.73 | 2.25 | 2.42 | 1.88 | 1.00 |
EPS (Diluted) | 1.53 | 1.73 | 2.25 | 2.42 | 1.88 | 1.00 |
EPS Growth | -30.23% | -23.28% | -6.96% | 29.01% | 88.59% | -30.95% |
Free Cash Flow | 209.7 | 202.49 | 356.72 | 408.45 | 379.07 | 111.13 |
Free Cash Flow Per Share | 1.31 | 1.27 | 2.23 | 2.55 | 2.37 | 0.69 |
Dividend Per Share | 1.040 | 1.040 | 1.370 | 1.460 | 1.130 | 0.600 |
Dividend Growth | -24.09% | -24.09% | -6.16% | 29.20% | 88.33% | -31.03% |
Gross Margin | 26.06% | 27.29% | 30.23% | 31.30% | 29.57% | 25.38% |
Operating Margin | 12.15% | 13.56% | 17.22% | 18.98% | 16.32% | 10.58% |
Profit Margin | 10.44% | 11.60% | 14.43% | 15.60% | 13.24% | 8.84% |
Free Cash Flow Margin | 8.96% | 8.49% | 14.27% | 16.44% | 16.70% | 6.17% |
EBITDA | 478.05 | 514.6 | 607.88 | 638.39 | 545.47 | 348.04 |
EBITDA Margin | 20.42% | 21.57% | 24.32% | 25.69% | 24.03% | 19.31% |
D&A For EBITDA | 193.74 | 191.04 | 177.33 | 166.75 | 174.88 | 157.3 |
EBIT | 284.31 | 323.56 | 430.55 | 471.64 | 370.59 | 190.73 |
EBIT Margin | 12.15% | 13.56% | 17.22% | 18.98% | 16.32% | 10.58% |
Effective Tax Rate | 19.73% | 19.84% | 19.73% | 19.76% | 19.84% | 18.06% |
Revenue as Reported | 2,341 | 2,386 | 2,500 | 2,485 | 2,270 | 1,802 |